Clinical Trials Browser

Phase 1 × INDUSTRY × rubitecan × Clear all

NCT00113113 2024-08-02

Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction

Phase 1 Completed

Liver Diseases, Neoplasms, Renal Insufficiency